Stress hormones increase cell proliferation and regulates interleukin-6 secretion in human oral squamous cell carcinoma cells

Brain, Behavior, and Immunity

Volumn 25, Issue 3, 2011, Pages 574-583

  Bernabé, Daniel G ^a   Tamae, Adriano C ^a   Biasoli, Éder R ^a   Oliveira, Sandra H P ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Beta adrenergic receptor; Cortisol; Interleukin 6; Norepinephrine; Oral cancer; Psychological stress; Squamous cell carcinoma

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; HYDROCORTISONE; INTERLEUKIN 6; ISOPRENALINE; MESSENGER RNA; NEUTRALIZING ANTIBODY; NORADRENALIN; PROPRANOLOL; STRESS HORMONE;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; FEMALE; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; ORAL SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION;

ADRENERGIC BETA-ANTAGONISTS; ANALYSIS OF VARIANCE; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; HYDROCORTISONE; INTERLEUKIN-6; ISOPROTERENOL; NOREPINEPHRINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 79551682548     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2010.12.012     Document Type: Article

References (41)

1. Antoni M.H., Lutgendorf S.K., Cole S.W., Dhabhar F.S., Sephton S.E., McDonald P.G., Stefanek M., Sood A.K. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat. Rev. Cancer 2006, 6:240-248.
2. Ardestani S.K., Inserra P., Solkoff D., Watson R.R. The role of cytokines and chemokines on tumor progression: a review. Cancer Detect. Prev. 1999, 23:215-225.
3. Askari M.D., Tsao M.S., Schuller H.M. The tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone stimulates proliferation of immortalized human pancreatic duct epithelia through beta-adrenergic transactivation of EGF receptors. J. Cancer Res. Clin. Oncol. 2005, 131:639-648.
4. Ben-Eliyahu S., Yirmiya R., Liebeskind J.C., Taylor A.N., Gale R.P. Stress increases metastatic spread of a mammary tumor in rats: evidence for mediation by the immune system. Brain Behav. Immun. 1991, 5:193-205.
5. Briest W., Rassler B., Deten A., Leicht M., Morwinski R., Neichel D., Wallukat G., Ziegelhöffer T., Zimmer H.G. Norepinephrine-induced interleukin-6 increase in rat hearts: differential signal transduction in myocytes and non-myocytes. Pflugers Arch. 2003, 446:437-446.
6. Cakir Y., Plummer H.K., Tithof F.P.K., Schuller H.M. Beta-adrenergic and arachidonic acid-mediated growth regulation of human breast cancer cell lines. Int. J. Oncol. 2002, 21:153-157.
7. Chakravarti N., Myers J.N., Aggarwal B.B. Targeting constitutive and interleukin-6-inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma cells by curcumin (diferuloylmethane). Int. J. Cancer 2006, 119:1268-1275.
8. Chan C., Lin H.J., Lin J. Stress-associated hormone, norepinephrine, increases proliferation and IL-6 levels of human pancreatic duct epithelial cells and can be inhibited by the dietary agent, sulforaphane. Int. J. Oncol. 2008, 33:415-419.
9. Chen S.C., Liao C.T., Lin C.C., Chang J.T., Lai Y.H. Distress and care needs in newly diagnosed oral cavity cancer patients receiving surgery. Oral Oncol. 2009, 45:815-820.
10. Duffy S.A., Taylor J.M., Terrell J.E., Islam M., Li Y., Fowler K.E., Wolf G.T., Teknos T.N. Interleukin-6 predicts recurrence and survival among head and neck cancer patients. Cancer 2008, 113:750-757.
11. Esterling B.A., Kiecolt-Glaser J.K., Glaser R. Psychosocial modulation of cytokine-induced natural killer cell activity in older adults. Psychosom. Med. 1996, 58:264-272.
12. Glaser R., Kiecolt-Glaser J.K. Stress-induced immune dysfunction: implications for health. Nat. Rev. Immunol. 2005, 5:243-251.
13. Hasan Q., Tan S.T., Xu B., Davis P.F. Effects of five commonly used glucocorticoids on haemangioma in vitro. Clin. Exp. Pharmacol. Physiol. 2003, 30:140-144.
14. Heikkilä K., Ebrahim S., Lawlor D.A. Systematic review of the association between circulating interleukin-6 (IL-6) and cancer. Eur. J. Cancer 2008, 44:937-945.
15. Hodge D.R., Hurt E.M., Farrar W.L. The role of IL-6 and STAT3 in inflammation and cancer. Eur. J. Cancer 2005, 41:2502-2512.
16. Kiecolt-Glaser J.K., Glaser R. Psychoneuroimmunology and cancer: fact or fiction?. Eur. J. Cancer 1999, 35:1603-1607.
17. Kiecolt-Glaser J.K., Preacher K.J., MacCallum R.C., Atkinson C., Malarkey W.B., Glaser R. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc. Natl. Acad. Sci. USA 2003, 100:9090-9095.
18. Kugaya A., Akechi T., Okuyama T., Nakano T., Mikami I., Okamura H., Uchitomi Y. Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer. Cancer 2000, 88:2817-2823.
19. Lillberg K., Verkasalo P.K., Kaprio J., Teppo L., Helenius H., Koskenvuo M. Stressful life events and risk of breast cancer in 10,808 women: a cohort study. Am. J. Epidemiol. 2003, 157:415-423.
20. Liu X., Wu W.K., Yu L., Sung J.J., Srivastava G., Zhang S.T., Cho C.H. Epinephrine stimulates esophageal squamous-cell carcinoma cell proliferation via beta-adrenoceptor-dependent transactivation of extracellular signal-regulated kinase/cyclooxygenase-2 pathway. J. Cell. Biochem. 2008, 105:53-60.
21. Lointier P., Wildrick D.M., Boman B.M. The effects of steroid hormones on a human colon cancer cell line in vitro. Anticancer Res. 1992, 12:1327-1330.
22. Lutgendorf S.K., Cole S., Costanzo E., Bradley S., Coffin J., Jabbari S., Rainwater K., Ritchie J.M., Yang M., Sood A.K. Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin. Cancer Res. 2003, 9:4514-4521.
23. Melamed R., Rosenne E., Shakhar K., Schwartz Y., Abudarham N., Ben-Eliyahu S. Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor. Brain Behav. Immun. 2005, 19:114-126.
24. Miller D.B., O'Callaghan J.P. Neuroendocrine aspects of the response to stress. Metabolism 2002, 51:5-10.
25. Nagata M., Fujita H., Ida H., Hoshina H., Inoue T., Seki Y., Ohnishi M., Ohyama T., Shingaki S., Kaji M., et al. Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysis. Int. J. Cancer 2003, 106:683-689.
26. Nilsson M.B., Armaiz-Pena G., Takahashi R., Lin Y.G., Trevino J., Li Y., Jennings N., Arevalo J., Lutgendorf S.K., Gallick G.E., et al. Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism. J. Biol. Chem. 2007, 282:29919-29926.
27. Okamoto M., Hiura K., Ohe G., Ohba Y., Terai K., Oshikawa T., Furuichi S., Nishikawa H., Moriyama K., Yoshida H., et al. Mechanism for bone invasion of oral cancer cells mediated by interleukin-6 in vitro and in vivo. Cancer 2000, 89:1966-1975.
28. Pelzmann M., Thurnher D., Gedlicka C., Martinek H., Knerer B. Nimesulide and indomethacin induce apoptosis in head and neck cancer cells. J. Oral Pathol. Med. 2004, 33:607-613.
29. Reiche E.M., Nunes S.O., Morimoto H.K. Stress, depression, the immune system, and cancer. Lancet Oncol. 2004, 5:617-625.
30. Rhodus N.L., Ho V., Miller C.S., Myers S., Ondrey F. NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma. Cancer Detect. Prev. 2005, 29:42-45.
31. Saul A.N., Oberyszyn T.M., Daugherty C., Kusewitt D., Jones S., Jewell S., Malarkey W.B., Lehman A., Lemeshow S., Dhabhar F.S. Chronic stress and susceptibility to skin cancer. J. Natl. Cancer Inst. 2005, 97:1760-1767.
32. Schuller H.M., Tithof P.K., Williams M., Plummer H. The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is a beta-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via beta-adrenergic receptor-mediated release of arachidonic acid. Cancer Res. 1999, 59:4510-4515.
33. Shang Z.J., Liu K., Liang D.F. Expression of beta(2)-adrenergic receptor in oral squamous cell carcinoma. J. Oral Pathol. Med. 2009, 38:371-376.
34. Shin V.Y., Wu W.K., Chu K.M., Koo M.W., Wong H.P., Lam E.K., Tai E.K., Cho C.H. Functional role of beta-adrenergic receptors in the mitogenic action of nicotine on gastric cancer cells. Toxicol. Sci. 2007, 96:21-29.
35. Sood A.K., Bhatty R., Kamat A.A., Landen C.N., Han L., Thaker P.H., Li Y., Gershenson D.M., Lutgendorf S., Cole S.W. Stress hormone-mediated invasion of ovarian cancer cells. Clin. Cancer Res. 2006, 12:369-375.
36. Thaker P.H., Lutgendorf S.K., Sood A.K. The neuroendocrine impact of chronic stress on cancer. Cell Cycle 2007, 6:430-433.
37. Thurnher D., Bakroeva M., Formanek M., Knerer B., Kornfehl J. Non-steroidal anti-inflammatory drugs inhibit telomerase activity in head and neck squamous carcinoma cell lines. Head Neck 2001, 23:1049-1055.
38. Yang E.V., Sood A.K., Chen M., Li Y., Eubank T.D., Marsh C.B., Jewell S., Flavahan N.A., Morrison C., Yeh P.E., et al. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res. 2006, 66:10357-10364.
39. Yang E.V., Donovan E.L., Benson D.M., Glaser R. VEGF is differentially regulated in multiple myeloma-derived cell lines by norepinephrine. Brain Behav. Immun. 2008, 22:318-323.
40. Yang E.V., Kim S.J., Donovan E.L., Chen M., Gross A.C., Webster Marketon J.I., Barsky S.H., Glaser R. Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain Behav. Immun. 2009, 23:267-275.
41. Yano A., Fujii Y., Iwai A., Kageyama Y., Kihara K. Glucocorticoids suppress tumor angiogenesis and in vivo growth of prostate cancer cells. Clin. Cancer Res. 2006, 12:3003-3009.